|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 401/04 | |||
| C07D 409/04 | |||
| C07D 409/14 | |||
| C07D 417/14 | |||
| A61K 31/4418 | |||
| A61K 31/444 | |||
| A61K 31/506 | |||
| A61P 3/00 | |||
| A61P 9/00 |
| (11) | Number of the document | 3114121 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15710687.3 |
| Date of filing the European patent application | 2015-03-05 | |
| (97) | Date of publication of the European application | 2017-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/018874 |
| Date | 2015-03-05 |
| (87) | Number | WO 2015/134701 |
| Date | 2015-09-11 |
| (30) | Number | Date | Country code |
| 201461949506 P | 2014-03-07 | US |
| (72) |
MENG, Wei, US
ZHAO, Guohua, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS |
| DIHYDROPYRIDINONE MGAT2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS |